These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2560821)
21. Electroacupuncture analgesia is mediated by stereospecific opiate receptors and is reversed by antagonists of type I receptors. Cheng RS; Pomeranz BH Life Sci; 1980 Feb; 26(8):631-8. PubMed ID: 6247596 [No Abstract] [Full Text] [Related]
22. Stereochemical studies on medicinal agents. 23. Synthesis and biological evaluation of 6-amino derivatives of naloxone and naltrexone. Jiang JB; Hanson RN; Portoghese PS; Takemori AE J Med Chem; 1977 Aug; 20(8):1100-2. PubMed ID: 894682 [TBL] [Abstract][Full Text] [Related]
23. Opiate receptor inhibition improves the blunted baroreflex function in conscious dogs with right-sided congestive heart failure. Sakamoto S; Liang CS Circulation; 1989 Oct; 80(4):1010-5. PubMed ID: 2551535 [TBL] [Abstract][Full Text] [Related]
24. Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice. Campillo A; Cabañero D; Romero A; García-Nogales P; Puig MM Eur J Pharmacol; 2011 Apr; 657(1-3):89-96. PubMed ID: 21300053 [TBL] [Abstract][Full Text] [Related]
25. Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors. Pasternak GW; Childers SR; Snyder SH Science; 1980 May; 208(4443):514-6. PubMed ID: 6245448 [TBL] [Abstract][Full Text] [Related]
27. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system. Kim S; Wagner HN; Villemagne VL; Kao PF; Dannals RF; Ravert HT; Joh T; Dixon RB; Civelek AC J Nucl Med; 1997 Nov; 38(11):1726-31. PubMed ID: 9374341 [TBL] [Abstract][Full Text] [Related]
28. Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice. Shoblock JR; Maidment NT Neuropsychopharmacology; 2006 Jan; 31(1):171-7. PubMed ID: 15956992 [TBL] [Abstract][Full Text] [Related]
30. Antinociceptive action of mitragynine in mice: evidence for the involvement of supraspinal opioid receptors. Matsumoto K; Mizowaki M; Suchitra T; Takayama H; Sakai S; Aimi N; Watanabe H Life Sci; 1996; 59(14):1149-55. PubMed ID: 8831802 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of selective mu-, kappa- and delta-opioid antagonists on electroshock seizure threshold in mice. Jackson HC; Nutt DJ Psychopharmacology (Berl); 1991; 103(3):380-3. PubMed ID: 1647539 [TBL] [Abstract][Full Text] [Related]
32. Radiosynthesis of [18F]3-acetylcyclofoxy: a high affinity opiate antagonist. Channing MA; Eckelman WC; Bennett JM; Burke TR; Rice KC Int J Appl Radiat Isot; 1985 Jun; 36(6):429-33. PubMed ID: 2993171 [TBL] [Abstract][Full Text] [Related]
33. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats. Célèrier E; Laulin J; Larcher A; Le Moal M; Simonnet G Brain Res; 1999 Nov; 847(1):18-25. PubMed ID: 10564731 [TBL] [Abstract][Full Text] [Related]
34. Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat. Guo TZ; Poree L; Golden W; Stein J; Fujinaga M; Maze M Anesthesiology; 1996 Oct; 85(4):846-52. PubMed ID: 8873555 [TBL] [Abstract][Full Text] [Related]
35. The anticonvulsant effects of DADLE are primarily mediated by activation of delta opioid receptors: interactions between delta and mu receptor antagonists. Tortella FC; Robles L; Holaday JW Life Sci; 1985 Aug; 37(6):497-503. PubMed ID: 2991684 [TBL] [Abstract][Full Text] [Related]
36. [Reversible binding of naloxazine and 14-hydroxydihydromorphazine with opiate receptors]. Li LY; Ye CY; Zhang PW; Tian M; Jin YC Yao Xue Xue Bao; 1984 Apr; 19(4):251-5. PubMed ID: 6093431 [No Abstract] [Full Text] [Related]
37. Opiate receptors in the periaqueductal gray mediate analgesic effect of nitrous oxide in rats. Fang F; Guo TZ; Davies MF; Maze M Eur J Pharmacol; 1997 Oct; 336(2-3):137-41. PubMed ID: 9384225 [TBL] [Abstract][Full Text] [Related]
38. Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors. Ochi T; Fujii T; Motoyama Y; Goto T Eur J Pharmacol; 1999 Sep; 380(2-3):73-9. PubMed ID: 10513565 [TBL] [Abstract][Full Text] [Related]
39. Antagonism by chlornaltrexamine of some effects of delta 9-tetrahydrocannabinol in rats. Tulunay FC; Ayhan IH; Portoghese PS; Takemori AE Eur J Pharmacol; 1981 Mar; 70(2):219-24. PubMed ID: 6266844 [TBL] [Abstract][Full Text] [Related]
40. Multiple opioid receptor profile in vitro and activity in vivo of the potent opioid antagonist Win 44,441-3. Ward SJ; Pierson AK; Michne WF Life Sci; 1983; 33 Suppl 1():303-6. PubMed ID: 6319882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]